Logo image of KMTS

KESTRA MEDICAL TECHNOLOGIES (KMTS) Stock Price, Quote, News and Overview

NASDAQ:KMTS - Nasdaq - BMG524411052 - Common Stock - Currency: USD

22.52  +0.33 (+1.49%)

After market: 22.52 0 (0%)

KMTS Quote, Performance and Key Statistics

KESTRA MEDICAL TECHNOLOGIES

NASDAQ:KMTS (5/27/2025, 8:00:02 PM)

After market: 22.52 0 (0%)

22.52

+0.33 (+1.49%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap1.16B
Shares51.35M
Float20.75M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO03-06 2025-03-06


KMTS short term performance overview.The bars show the price performance of KMTS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6 -8 -10

KMTS long term performance overview.The bars show the price performance of KMTS in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of KMTS is 22.52 USD. In the past month the price decreased by -10.35%.

KESTRA MEDICAL TECHNOLOGIES / KMTS Daily stock chart

KMTS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.81 231.29B
ISRG INTUITIVE SURGICAL INC 72.01 197.20B
BSX BOSTON SCIENTIFIC CORP 39.32 157.07B
SYK STRYKER CORP 30.63 146.67B
MDT MEDTRONIC PLC 14.76 104.12B
BDX BECTON DICKINSON AND CO 12.39 50.02B
EW EDWARDS LIFESCIENCES CORP 29.32 44.71B
IDXX IDEXX LABORATORIES INC 45.31 41.86B
RMD RESMED INC 27.12 36.10B
DXCM DEXCOM INC 51.72 33.46B
GEHC GE HEALTHCARE TECHNOLOGY 15.44 32.51B
STE STERIS PLC 26.36 24.19B

About KMTS

Company Profile

Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Company Info

KESTRA MEDICAL TECHNOLOGIES

3933 Lake Washington Blvd Ne, Suite 200

Kirkland WASHINGTON US

Employees: 0

Phone: 14252798002

KESTRA MEDICAL TECHNOLOGIES / KMTS FAQ

What is the stock price of KESTRA MEDICAL TECHNOLOGIES today?

The current stock price of KMTS is 22.52 USD. The price increased by 1.49% in the last trading session.


What is the ticker symbol for KESTRA MEDICAL TECHNOLOGIES stock?

The exchange symbol of KESTRA MEDICAL TECHNOLOGIES is KMTS and it is listed on the Nasdaq exchange.


On which exchange is KMTS stock listed?

KMTS stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for KESTRA MEDICAL TECHNOLOGIES stock?

12 analysts have analysed KMTS and the average price target is 28.05 USD. This implies a price increase of 24.56% is expected in the next year compared to the current price of 22.52. Check the KESTRA MEDICAL TECHNOLOGIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is KESTRA MEDICAL TECHNOLOGIES worth?

KESTRA MEDICAL TECHNOLOGIES (KMTS) has a market capitalization of 1.16B USD. This makes KMTS a Small Cap stock.


How many employees does KESTRA MEDICAL TECHNOLOGIES have?

KESTRA MEDICAL TECHNOLOGIES (KMTS) currently has 0 employees.


What are the support and resistance levels for KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?

KESTRA MEDICAL TECHNOLOGIES (KMTS) has a support level at 22.19 and a resistance level at 24.62. Check the full technical report for a detailed analysis of KMTS support and resistance levels.


Is KESTRA MEDICAL TECHNOLOGIES (KMTS) expected to grow?

The Revenue of KESTRA MEDICAL TECHNOLOGIES (KMTS) is expected to grow by 113.57% in the next year. Check the estimates tab for more information on the KMTS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does KESTRA MEDICAL TECHNOLOGIES (KMTS) stock pay dividends?

KMTS does not pay a dividend.


What is the Price/Earnings (PE) ratio of KESTRA MEDICAL TECHNOLOGIES (KMTS)?

KESTRA MEDICAL TECHNOLOGIES (KMTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.04).


What is the Short Interest ratio of KESTRA MEDICAL TECHNOLOGIES (KMTS) stock?

The outstanding short interest for KESTRA MEDICAL TECHNOLOGIES (KMTS) is 4.08% of its float. Check the ownership tab for more information on the KMTS short interest.


KMTS Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to KMTS.


Chartmill TA Rating
Chartmill Setup Rating

KMTS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to KMTS. Both the profitability and financial health of KMTS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

KMTS Financial Highlights

Over the last trailing twelve months KMTS reported a non-GAAP Earnings per Share(EPS) of -2.04. The EPS decreased by -16.26% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -83.03%
ROE -365.94%
Debt/Equity 1.57
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-16.26%
Revenue 1Y (TTM)264.53%

KMTS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to KMTS. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 0.96% and a revenue growth 113.57% for KMTS


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %4.08%
Short Ratio6.31
Analysts
Analysts85
Price Target28.05 (24.56%)
EPS Next Y0.96%
Revenue Next Year113.57%